
|Videos|November 22, 2021
Topical oxymetazoline 0.1% and upper lid elevation: An overview with Shane Foster, OD
Author(s)Shane Foster, OD, Brooke Henson, Editor
Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) provides significant improvement in upper eyelid elevation for ptosis patients
Advertisement
Shane Foster, OD discusses highlights from his American Academy of Optometry poster presentation on upper eyelid elevation in acquired ptosis patients with once-daily topical Oxymetazoline 0.1%.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA expands TearCare indication to improve meibomian gland function
2
FDA accepts NDA for bimatoprost grenod in open-angle glaucoma and OHT
3
Catching keratoconus early in pediatric patients: Why timing matters
4
Not all myopia is the same: Noha Ekdawi, MD, FAAP, on individualized management
5















